Tumor cells overexpressing CD44 demonstrate numerous characteristics of cancer stem cells (CSCs), including the ability to self-renew, high potential for tumor initiation, capacity for epithelial–mesenchymal transition (EMT), and resistance to chemotherapy [13,14]. This evidence concerns the gene CD44 and cancer.